³í¹®) Effects of CYP2C19 genetic polymorphisms on the pharmacokinetics of lacosamide in Korean patients with epilepsy ¼¿ï´ëº´¿ø ½Å°æ°ú ÀÌ»ó°Ç(»çÁø ñ§)·ÁÖ°Ç(ñé), ÀÔ¿øÀÇÇм¾ÅÍ ¾È¼±Àç ±³¼ö(éÓ)